Validation of the UK version of the overactive bladder questionnaire (OAB-q) in continent and incontinent patients with overactive bladder (OAB)
Pleil A1, Coyne K2 1. Pfizer Inc, 2. MEDTAP International
Abstract Category
Epidemiology & Outcomes Research
|
|
Abstract 407
|
|
|
Read By Title:
Scientific Non Discussion Abstract Session 21
|
|
|